Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Leukemia
42%
Cyclophosphamide
36%
Bone Marrow
30%
Cytarabine
27%
Survival
25%
Graft vs Host Disease
22%
Transplantation
21%
tipifarnib
19%
Recurrence
17%
Histone Deacetylase Inhibitors
17%
Neoplasms
17%
entinostat
16%
Consolidation Chemotherapy
16%
Therapeutics
15%
Transplants
15%
Homologous Transplantation
14%
Acute Promyelocytic Leukemia
13%
Myelodysplastic Syndromes
13%
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
13%
veliparib
13%
Mitoxantrone
13%
Etoposide
13%
alvocidib
13%
Drug Therapy
12%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12%
Philadelphia Chromosome
11%
Pharmacokinetics
11%
GATA2 Deficiency
11%
Multiple Myeloma
11%
Vorinostat
11%
Ribonucleotide Reductases
11%
Hematologic Neoplasms
11%
Topotecan
11%
Guidelines
9%
Poly(ADP-ribose) Polymerase Inhibitors
9%
Intercellular Signaling Peptides and Proteins
8%
Cytogenetics
8%
Stem Cell Transplantation
8%
Maximum Tolerated Dose
8%
Biphenotypic Acute Leukemia
8%
T-Lymphocytes
8%
Haploidentical Transplantation
8%
Farnesyltranstransferase
8%
Primary Myelofibrosis
8%
pembrolizumab
8%
MK-8776
7%
Progression-Free Survival
7%
Azacitidine
7%